Stock Events

Stock Events

Regent Pacific Group Limited 

$0.01
1
-$0.12-95.28% Monday 20:00

Statistics

Day High
0.13
Day Low
0.13
52W High
0.43
52W Low
0
Volume
40
Avg. Volume
25
Mkt Cap
1.72M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Mar 13
$0.34
Feb 12
$0.08
Jan 11
$0.05
Jul 10
$0.03
Oct 9
$0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30JunExpected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-0.01
-0.01
-0
0
Expected EPS
0
Actual EPS
0.0006

Financials

-623.37%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
1.44MRevenue
-8.96MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RPGLF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline plc is a major player in the pharmaceuticals sector, competing in various therapeutic areas similar to Regent Pacific.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. operates in the global pharmaceutical market, directly competing in the development and marketing of medical solutions.
Novartis
NVS
Mkt Cap237.61B
Novartis AG is known for its extensive research and development in pharmaceuticals, overlapping with Regent Pacific's market interests.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. competes in the pharmaceutical industry, focusing on innovative therapies where Regent Pacific also operates.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson offers a broad range of health products, competing across several of the same therapeutic areas as Regent Pacific.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. engages in the development of pharmaceutical products, directly competing with Regent Pacific in specific therapeutic categories.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. focuses on biotechnological medicines, including areas that overlap with Regent Pacific's product lines.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb Company operates in the global biopharmaceutical market, competing in the same sphere as Regent Pacific.
Sanofi
SNY
Mkt Cap124.45B
Sanofi focuses on pharmaceuticals and treatments that compete with Regent Pacific's products in various global markets.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC competes in the pharmaceutical sector, developing drugs in areas that potentially compete with Regent Pacific's offerings.

About

Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services.
Show more...
CEO
Mr. Jamie Alexander Gibson
Employees
13
Country
US
ISIN
KYG3042R1314

Listings

HK
HK
575.HK
HK
HK
1239.HK
HK
HK
559.HK
HK
HK
1413.HK

0 Comments

Share your thoughts

FAQ

What is Regent Pacific Group Limited stock price today?▼
The current price of RPGLF is $0.01 USD — it has decreased by -95.28% in the past 24 hours. Watch Regent Pacific Group Limited stock price performance more closely on the chart.
What is Regent Pacific Group Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Regent Pacific Group Limited stocks are traded under the ticker RPGLF.
What is Regent Pacific Group Limited market cap?▼
Today Regent Pacific Group Limited has the market capitalization of 1.72M
What were Regent Pacific Group Limited earnings last quarter?▼
RPGLF earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Regent Pacific Group Limited revenue for the last year?▼
Regent Pacific Group Limited revenue for the last year amounts to 1.44M USD.
What is Regent Pacific Group Limited net income for the last year?▼
RPGLF net income for the last year is -8.96M USD.
Does Regent Pacific Group Limited pay dividends?▼
Yes, RPGLF dividends are paid annual. The last dividend per share was 0.34 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Regent Pacific Group Limited have?▼
As of April 02, 2026, the company has 13 employees.
In which sector is Regent Pacific Group Limited located?▼
Regent Pacific Group Limited operates in the Financials sector.
When did Regent Pacific Group Limited complete a stock split?▼
The last stock split for Regent Pacific Group Limited was on June 05, 2023 with a ratio of 1:20.
Where is Regent Pacific Group Limited headquartered?▼
Regent Pacific Group Limited is headquartered in Central, US.